Cytoplasmic Skp2 Expression Is Increased in Human Melanoma and Correlated with Patient Survival
2011

Increased Skp2 Expression in Melanoma Linked to Patient Survival

Sample size: 713 publication 10 minutes Evidence: moderate

Author Information

Author(s): Chen Guangdi, Cheng Yabin, Zhang Zhizhong, Martinka Magdalena, Li Gang

Primary Institution: University of British Columbia

Hypothesis

The study investigates the role of Skp2 expression in melanoma development and its correlation with patient survival.

Conclusion

Cytoplasmic Skp2 expression is associated with poor survival outcomes in primary melanoma patients.

Supporting Evidence

  • Cytoplasmic Skp2 expression increased from normal nevi to metastatic melanomas.
  • High cytoplasmic Skp2 expression correlated with poor five-year disease-specific survival.
  • No significant correlation was found between nuclear Skp2 expression and patient survival.

Takeaway

This study found that higher levels of a protein called Skp2 in melanoma patients can mean they might not live as long.

Methodology

The study used tissue microarrays and immunohistochemistry to assess Skp2 expression in various stages of melanocytic lesions.

Potential Biases

Potential biases in patient selection and retrospective analysis of survival data.

Limitations

The study may not account for all variables affecting patient survival, and the correlation does not imply causation.

Participant Demographics

The study included 436 melanoma patients, with a median age of 60 years, comprising 258 men and 178 women.

Statistical Information

P-Value

P<0.001 for AJCC stages correlation

Confidence Interval

95% CI for hazard ratios reported in the study

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0017578

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication